TH801004154A - Pharmaceutical components containing sex steroid precursors - Google Patents

Abstract

DC60 (16/10/51) A new method for the treatment or reduction of pre-menopausal syndromes or diseases, in women after menopause, especially osteoporosis, wilt. And vaginal dryness, hypogonadism, decreased sex drive, skin worsening, dysentery, incontinence, breast cancer, endometriosis, ovaries and uterus, hot Flashes, loss of muscle mass, insulin resistance, fatigue, wasting of energy, aging and neurological syndromes. The physical of menopause, in sensitive warm-blooded animals including humans involved in drug administration of the reagent. The sex steroid tree was exposed. The above method consists of A new way of giving and administering dehydroepine Androsterones (DHEA) in order to benefit from the effects that give positive male characteristics in the propion class. Thinning of the vagina And / or muskularis, without the undesiredness of the resulting Female characteristics throughout the body In order to avoid the risk of breast and uterine cancer. Pharmaceutical composition For the delivery of the active ingredient, the invention was also revealed. New methods for the treatment or reduction of the symptoms of aggravation or acquired dracaena due to Menopause, in women after menopause, especially Osteoporosis, wilt and dryness of the cavity. Prenatal hypogonadism, decreased sexual desire, skin wilt, recurrent disease, incontinence, breast cancer, ovarian and uterine mucosa, hot flashes , The loss of mass Muscles, Insulin Resistance, Fatigue, Wasted Energy, Aging And clinical syndromes The physical of menopause, in sensitive warm-blooded animals including humans involved in drug administration of the reagent. Gender stereos are exposed. The method consists of A new way of taking and administering dehydroipi Androsterones (DHEA) in order to obtain the benefits of a positive male effect on the propion class. Thinning of the vagina And / or muskularis, without the undesiredness of the resulting Female characteristics throughout the body To avoid the risk of breast and uterine cancer Pharmaceutical composition As for the delivery of components, the usefulness of the invention was revealed as well.

Claims (1)

: DC60 (16/10/51) New methods for the treatment or reduction of the pre-menopausal syndrome, in women after menopause, especially osteoporosis, Wilt and dryness of the vagina, hypogonadism, decreased sex drive, skin wilting, disease of reluctance, incontinence, breast cancer, endometriosis, ovaries and uterus, Hot flashes, loss of muscle mass, insulin resistance, fatigue, wasting of energy, aging and neurological syndromes. The physical of menopause, in sensitive warm-blooded animals including humans involved in drug administration of the reagent. The sex steroid tree was exposed. The above method consists of A new way of giving and administering dehydroepine Androsterones (DHEA) in order to benefit from the effects that give positive male characteristics in the propion class. Thinning of the vagina And / or muskularis, without the undesiredness of the resulting Female characteristics throughout the body In order to avoid the risk of breast and uterine cancer. Pharmaceutical composition For the delivery of the active ingredient, the invention was also revealed. New methods for the treatment or reduction of the symptoms of aggravation or acquired dracaena due to Menopause, in women after menopause, especially Osteoporosis, wilt and dryness of the cavity. Prenatal hypogonadism, decreased sexual desire, skin wilt, recurrent disease, incontinence, breast cancer, ovarian and uterine mucosa, hot flashes , The loss of mass Muscles, Insulin Resistance, Fatigue, Wasted Energy, Aging And clinical syndromes The physical of menopause, in sensitive warm-blooded animals including humans involved in drug administration of the reagent. Gender stereos are exposed. The method consists of A new way of taking and administering dehydroipi Androsterones (DHEA) in order to obtain the benefits of a positive male effect on the propion class. Thinning of the vagina And / or muskularis, without the undesiredness of the resulting Female characteristics throughout the body To avoid the risk of breast and uterine cancer Pharmaceutical composition As for the delivery of components, a mechanism that is beneficial to the invention was also disclosed. (Section one) which will appear on the advertisement page: edit 17/06/2019. 1. Axial components for vaginal administration, including substrate Selected sex steroids from a group containing dehydroepiandroosterones, kihichroipiancrosterone sulfate, ancrost-5-eine. -3 (symbol), 17 (symbol) -Diol, and 4- andros 3,17-dion. And supplemented with sections Add a drug, a stabilizer or a pharmaceutical carrier that has been formulated to provide a dosage form. Initial such sex steroids are 13mg or less per dose. Use ----- Tag: drug patent.